Cell-Based Assay Market worth $14.8 Billion by 2018
DALLAS, May 7, 2014 /PRNewswire/ –
According to new market research report the “Cell-Based Assays Market by Product
(Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software
& Assay Development Services), Application (Drug Discovery, ADMET), End-user
(Pharmaceutical, CRO) – Global Forecast to 2018″, published by MarketsandMarkets, The
global Cell-Based Assay Market is poised to reach $14.8 Billion by 2018, at a CAGR of
Browse 88 Market Data Tables and 19 Figures spread through 243 Pages and in-depth TOC
on “Cell-Based Assays Market”
Early buyers will receive 10% customization on this report.
This report studies the global cell-based assays market over the forecast period of
2013 to 2018.
The major market propellants for cell-based assays are benefits of cell-based assays
over biochemical assays and animal models and public-private partnerships for drug
discovery. The growth market is also driven by continuous innovations and developments in
the market aimed at higher throughput.
The opportunities for the growth of this market include developments in emerging
markets such as Asia, introduction of technologically advanced products, and increase need
of toxicity screening. However, factors such as intellectual property rights are
restricting innovation in the market and hence hindering growth. The optimization of assay
for cell-based assay is still a challenge while complexity of HTS assays and assay
standardization and validation is still an unmet need. However, some revolutionary
platforms like label-free technology, 3D assays, induced pluripotent stem cells are
expected to gain traction in future.
This research report categorizes and analyzes the global Cell-Based Assay Market on
the basis of products, applications, end-users and geography in the cell-based assay
market. All these markets are further divided into segments and sub-segments, to provide
exhaustive value analysis for the years 2011, 2012, 2013, and forecast to 2018. Based on
the cell-based assay product type, consumables (assay kits, reagents, microplates, cell
lines), detection and screening instruments, automation and high throughput screening
instruments, software and services form the overall cell-based assay market. Under
applications market for cell-based assay drug discovery, ADME studies, predictive
toxicology and basic research are covered. The end-users market covers academic and
government institutions, pharmaceutical and biotechnology companies, and contract research
North America accounted for the largest market share of the cell-based assay market,
followed by Europe, in 2013. However, Asia presents significant opportunities for
investors as the developed markets get saturated.
The major players included in this report are BD Biosciences (U.S.) , Danaher
Corporation (U.S.), DiscoveRx (U.S.), EMD Millipore (Germany), GE Healthcare (U.K.), Life
Technologies Corporation (U.S.), PerkinElmer (U.S.), and Promega Corporation (U.S.).
Browse related reports
High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High
Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target
Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical
Industry, Biotechnology Industry, CRO) – Forecast to 2018.
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR),
Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation,
Cytology, Signal Transduction, Single Cell Analysis) – Global Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. MarketsandMarkets covers thirteen industry verticals, including
advanced materials, automotive and transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial
automation, medical devices, pharmaceuticals, healthcare IT semiconductor and electronics,
and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
North – Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog
with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets